NEON Nasdaq Electronic Components, Nec Financials FY2016βFY2025
Neonode Inc. had $2.1M of revenue in fiscal 2025, down 33.7% on the year before. Over five years, revenue changed β19.2% a year on average.
Last close Β· Oct 23, 2026
$0.75
0.2%Hi! I read Neonode Inc.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
β33.7%
No. Sales fell 33.7% last year.
Does it make a profit?
411.9%
Yes. It keeps 411.9% of every sale as profit.
Does profit turn into cash?
β501.7%
No. It spent more cash than it brought in.
How healthy are the accounts?
4 / 7
Mixed. It passes 4 of 7 health tests.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days Neonode Inc. did it, and the next one. Share prices often move a lot on those days.
Next results
November 5, 2026
Thursday Β· in 11 days
No past results dates on file yet.
KIRA Β· Neonode Inc. had $2.1M of revenue in fiscal 2025, down 33.7% on the year before. Over five years, revenue changed β19.2% a year on average. Its operating margin was 357.5%, up 568.1Β pts: of every 100 in sales, about 357 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
KIRA Β· Neonode Inc. made $8.5M of net profit in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$10.3M in fiscal 2025, β501.7% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
Cash, debt and the ratios that show how comfortably Neonode Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $17.4M | $14.8M | $16.2M | $16.4M | $25.4M |
| Interest coverage | β473.8x | β | β | β | β |
| Current ratio | 7.4x | 12.2x | 10.2x | 10.9x | 12.1x |
| Quick ratio | 6.6x | 11.9x | 9.8x | 10.9x | 12.1x |
| Total assets | $23.0M | $21.2M | $19.0M | $18.4M | $26.9M |
| Total liabilities | $3.2M | $1.8M | $1.9M | $1.9M | $2.2M |
| Shareholders' equity | $19.8M | $19.4M | $17.2M | $16.4M | $24.7M |
| Net debt (β = net cash) | β | β | β | β | β |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
KIRA Β· Neonode Inc. passes 4 of 7 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 8 | 4 / 8 | 3 / 8 | 3 / 8 | 3 / 8 | 4 / 8 | 2 / 8 | 3 / 8 | 4 / 7 |
| Accruals ratio | 9.9% | 7.7% | β1.5% | β17.2% | β4.4% | 6.2% | 8.7% | β19.0% | β4.7% | 82.8% |
| Altman Z'' | β60.80 | β43.53 | β39.91 | β84.71 | β33.58 | β18.77 | β16.22 | β23.81 | β27.50 | β6.61 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $10.2M | $10.2M | $8.5M | $6.6M | $6.0M | $5.8M | $5.7M | $3.8M | $3.1M | $2.1M |
| Gross profit | $8.9M | $7.9M | $7.6M | $6.0M | $4.9M | $4.9M | $4.9M | $3.8M | $3.0M | $2.0M |
| Research and development | $7.1M | $6.1M | $5.3M | $5.2M | $4.1M | $3.5M | $4.0M | $3.8M | $3.4M | $3.8M |
| Operating income | β$5.1M | β$5.5M | β$3.9M | β$5.7M | β$6.2M | β$7.1M | β$5.3M | β$5.7M | β$6.5M | $7.4M |
| Interest expense | $0.0M | $0.1M | $0.0M | $0.0M | $0.0M | $0.0M | β | β | β | β |
| Pretax income | β$5.3M | β$5.6M | β$3.9M | β$5.8M | β$6.2M | β$7.1M | β$5.2M | β$5.0M | β$5.9M | $8.0M |
| Income tax | $0.4M | β$0.1M | $0.0M | $0.0M | $0.1M | $0.1M | $0.1M | $0.1M | $0.0M | β$0.0M |
| Net income | β$5.3M | β$4.7M | β$3.1M | β$5.3M | β$6.3M | β$6.5M | β$4.9M | β$10.1M | β$6.5M | $8.5M |
| Net income to common | β | β | β | β$5.3M | β$5.6M | β$6.5M | β | β | β | β |
| Diluted EPS | β$0.12 | β$0.89 | β$0.52 | β$0.60 | $0.56 | β$0.54 | β$0.36 | β$0.66 | β$0.41 | β |
| Diluted shares | 0.05B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | β |
| Cash flow | ||||||||||
| Cash from operations | β$6.3M | β$5.6M | β$2.9M | β$3.5M | β$5.8M | β$7.7M | β$6.8M | β$6.3M | β$5.6M | β$10.3M |
| Capital expenditure | $1.0M | $0.7M | $0.2M | $0.1M | $0.1M | β | $0.1M | $0.1M | $0.0M | $0.1M |
| Free cash flow | β$7.2M | β$6.2M | β$3.1M | β$3.6M | β$5.8M | β | β$6.9M | β$6.4M | β$5.6M | β$10.3M |
| Depreciation and amortization | $0.4M | $1.0M | $1.0M | $0.9M | $0.8M | $0.6M | $0.1M | $0.0M | $0.1M | $0.1M |
| Stock-based compensation | $0.3M | $0.1M | $0.0M | β | $0.1M | $0.2M | $0.1M | $0.1M | $0.0M | $0.0M |
| Share buybacks | β | β | β | β | β | β | $0.0M | β | β | β |
| Dividends and buybacks | β | β | β | β | β | β | $0.0M | β | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $3.5M | $5.8M | $6.6M | $2.4M | $10.5M | $17.4M | $14.8M | $16.2M | $16.4M | $25.4M |
| Finance lease liabilities | β | β | β | $1.1M | $0.9M | $0.3M | $0.1M | $0.1M | $0.0M | $0.0M |
| Current assets | $7.7M | $9.8M | $10.5M | $5.4M | $14.7M | $22.0M | $20.8M | $18.6M | $17.7M | $26.3M |
| Current liabilities | $4.6M | $3.6M | $2.3M | $3.0M | $4.2M | $3.0M | $1.7M | $1.8M | $1.6M | $2.2M |
| Inventory | $0.7M | $1.2M | $1.2M | $1.0M | $1.3M | $2.5M | $0.6M | $0.6M | β | β |
| Property and equipment, net | $2.0M | $3.3M | $2.5M | $1.6M | $1.0M | $0.4M | $0.3M | $0.1M | $0.1M | $0.1M |
| Total assets | $9.7M | $13.1M | $13.2M | $7.4M | $16.6M | $23.0M | $21.2M | $19.0M | $18.4M | $26.9M |
| Total liabilities | $5.6M | $5.3M | $3.4M | $3.6M | $4.7M | $3.2M | $1.8M | $1.9M | $1.9M | $2.2M |
| Preferred stock | β | β | β | β | β | β | β | β | $0.0M | $0.0M |
| Shareholders' equity | $4.5M | $9.0M | $11.8M | $6.4M | $15.1M | $19.8M | $19.4M | $17.2M | $16.4M | $24.7M |
| Margins | ||||||||||
| Gross margin | 86.9% | 77.1% | 89.2% | 89.7% | 82.0% | 83.6% | 85.8% | 99.7% | 96.3% | 98.7% |
| Operating margin | β50.4% | β53.5% | β45.4% | β86.2% | β103.5% | β121.8% | β93.2% | β149.8% | β210.6% | 357.5% |
| EBITDA margin | β46.8% | β44.2% | β33.6% | β73.4% | β90.6% | β110.9% | β91.1% | β148.6% | β208.8% | 359.9% |
| Net margin | β51.8% | β45.9% | β35.8% | β79.7% | β105.0% | β110.5% | β86.1% | β264.4% | β208.0% | 411.9% |
| FCF margin | β70.9% | β60.9% | β36.2% | β54.3% | β97.1% | β | β121.0% | β168.0% | β181.1% | β501.7% |
| Returns | ||||||||||
| Return on capital employed | β101.0% | β57.4% | β35.5% | β129.8% | β50.1% | β35.5% | β27.1% | β33.4% | β39.1% | 29.8% |
| Return on equity | β117.4% | β69.6% | β29.3% | β58.1% | β58.4% | β36.9% | β24.9% | β55.3% | β38.5% | 41.3% |
| Return on assets | β54.5% | β41.2% | β23.2% | β51.2% | β52.3% | β32.6% | β22.1% | β50.3% | β34.6% | 37.5% |
| Return on tangible equity | β117.4% | β52.1% | β25.8% | β82.9% | β37.3% | β32.5% | β25.1% | β59.0% | β39.3% | 34.4% |
| Growth | ||||||||||
| Revenue growth | β | 0.3% | β16.6% | β22.2% | β10.0% | β2.5% | β2.8% | β32.5% | β18.8% | β33.7% |
| EPS growth | β | β | β | β | β | β196.4% | β | β | β | β |
| Share count change | β | β100.0% | 11.3% | 49.2% | 13.6% | 19.0% | 14.3% | 12.5% | 3.9% | β |
| Financial health | ||||||||||
| Interest coverage | β109.4x | β73.0x | β79.1x | β168.5x | β229.3x | β473.8x | β | β | β | β |
| Current ratio | 1.7x | 2.7x | 4.5x | 1.8x | 3.5x | 7.4x | 12.2x | 10.2x | 10.9x | 12.1x |
| Quick ratio | 1.5x | 2.4x | 4.0x | 1.5x | 3.2x | 6.6x | 11.9x | 9.8x | 10.9x | 12.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 9.7% | 6.4% | 2.8% | 1.3% | 1.0% | β | 0.9% | 3.2% | 1.2% | 4.4% |
| Stock comp / revenue | 2.5% | 0.7% | 0.3% | β | 1.3% | 2.7% | 2.2% | 1.5% | 0.1% | 0.0% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 4.0 | 3.0 | 3.0 | 3.0 | 4.0 | 2.0 | 3.0 | 4.0 |
| Altman Z'' | β60.8 | β43.5 | β39.9 | β84.7 | β33.6 | β18.8 | β16.2 | β23.8 | β27.5 | β6.6 |
| Accruals ratio | 9.9% | 7.7% | β1.5% | β17.2% | β4.4% | 6.2% | 8.7% | β19.0% | β4.7% | 82.8% |
Source: SEC EDGAR XBRL filings (CIK 0000087050). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
